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Incidence of and outcomes after misaligned
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Ronald M. Fairman, MD,c Atlanta, Ga; Boston, Mass; and Philadelphia, Pa
Objective: Various types of device-specific adverse events can occur during deployment of thoracic stent grafts due to the
high flow rate and severe aortic angulation that is often encountered in the thoracic aorta. This study assessed the
incidence, etiology, and overall effect of misaligned deployment of the Talent Thoracic Stent Graft (TSG) System.
Techniques to predict and avoid this complication are discussed.
Methods: Data collection included pivotal-trial follow-up, direct surveys of centers inside and outside the United States
and principal investigators, a targeted literature search, and review of complaint files. Misaligned deployment was
considered to occur when the proximal covered or uncovered stent apices of a thoracic stent graft folded back on itself and
remained nonparallel to the wall of the aorta after deployment had been completed.
Results: Of about 20,305 deployments to date of the Talent TSG, 24 misaligned deployments were identified for an
incidence of 0.1%. Nineteen (79%) events occurred during treatment of degenerative aneurysms or penetrating ulcers,
four (17%) during treatment of dissections, and the underlying pathology could not be determined for one patient. The
misalignment was noted at the proximal end of the stent graft in 15 patients (63%), and the other 9 events (37%) occurred
at the graft overlap junction. Two events were treated intraoperatively, with a second overlapping device placed in one
patient and a snare used to reposition the proximal stent in another. Adverse clinical events occurred in three patients and
included a persistent type I endoleak, continued false lumen perfusion in a patient with dissection, and delayed retrograde
type A dissection in a patient undergoing total arch repair. No intraoperative contrast extravasation or computed
tomography evidence of perforation was noted. There were no perioperative deaths or cerebrovascular events, with one
report of paraplegia among the 24 patients in this series.
Conclusion:Misaligned deployment is an unusual phenomenon that tends to occur in the context of certain well-defined
anatomic conditions in the thoracic aorta. To date, most of these events have not led to significant adverse sequelae.
However, careful patient selection, periprocedural imaging, and case planning can help to identify anatomies in which
misaligned opening is likely to occur, allowing physicians to avoid this complication. (J Vasc Surg 2010;51:1096-102.)In the experience with thoracic endovascular aneurysm
repair (TEVAR), stent graft failure has been found to occur
most frequently in the early perioperative period or during
late follow-up.1 The circumstances of TEVAR differ from
those of endovascular abdominal aneurysm repair (EVAR)
in terms of the tortuosity of the thoracic aorta, which
cannot be easily corrected with stiff wires, the greater
hemodynamic forces in the aortic arch, and the remoteness
of the pathology from the procedure entry site leading to an
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1096increased risk of device-related complications.2 Early
TEVAR failures involve delivery, deployment, and confor-
mation to the local aortic anatomy. Deployment failures,
which are rare but difficult to correct, usually occur in
situations of severe aortic tortuosity and near the distal
arch.1
Misaligned deployment can occur when the proximal
stent apices of a deployed stent graft retroflex and remain
significantly nonparallel to the wall of the aorta after de-
ployment has been completed. Potential clinical sequelae of
misaligned deployment may range from negligible to sig-
nificant and may present acutely or chronically.
The worldwide experience during the past decade with
the Talent Thoracic Stent Graft (TSG) System (Medtronic
Vascular, Santa Rosa, Calif) has been reported in numerous
articles.3-9 The Talent device received the Conformite Eu-
ropean (CE) mark in April 1998 and United States (US)
Food and Drug Administration (FDA) approval in June
2008. Currently, 20,305 Talent TSG devices have been
implanted in 7547 patients worldwide.
In the pivotal VALOR (Evaluation of the Medtronic
Vascular Talent Thoracic Stent Graft System for the Treat-
ment of Thoracic Aortic Aneurysms) trial, which enrolled
195 patients between December 2003 and June 2005, the
bare spring segment of the most proximally implanted
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33.5% of patients, and overall, no instances of misaligned
deployment were reported.9 Nevertheless, a small number
of reports of misaligned deployment events have been
documented related to the proximal bare spring and the
proximal covered stent, especially when deployed in tortu-
ous anatomy. We report the results of a thorough program
of data collection and event adjudication that was under-
taken to evaluate the incidence and clinical significance of
misaligned proximal stent deployment occurring during
deployment of the Talent TSG System.
METHODS
Device description and deployment.The Talent TSG
System is composed of a series of shaped sinusoidal nitinol
wire rings acting as springs stacked in a tubular arrange-
ment to form the self-expanding structure. These rings are
covered by a sewn-on monofilament polyester woven graft
with radiopaque markers attached. The overall design con-
cept is modular, with additional main sections as well as
proximal and distal extensions available for introduction
separately for mating in vivo as necessary for completing
thoracic aortic aneurysm (TAA) exclusion. The proximal
end of the stent graft can be configured as a serrated
proximal covered stent (open-web) or as an open bare-stent
(free-flow) segment. The bare-stent configuration allows
device implantation across the orifice of the left subclavian
or common carotid artery while maintaining antegrade
blood flow through these branch vessels.
The loaded delivery system is inserted most commonly
through the femoral or iliac artery, tracks through the
vasculature, and delivers the stent graft at the target site.
Deployment of the proximal stent graft occurs as the outer
sheath is withdrawn, initially exposing the proximal bare
spring and first covered stent graft.
Data collection. The purpose of the data collection
process was to assemble information about reports of mis-
aligned deployment of the proximal portion of the Talent
TSG device (also referred to as bare spring flip or eversion).
Misaligned deployment was defined as occurring when the
proximal stent apices of a deployed stent graft remained
significantly nonparallel to the wall of the aorta after de-
ployment was completed (Fig 1). Two levels of severity of
misaligned deployment were defined. Severity level 1 was
defined for cases of unresolved mild asymmetry or stent
apex protrusion into the aortic wall without clinical effect,
including no evidence of endoleak, graft narrowing or
occlusion, perforation, or retrograde dissection. Severity
level 2 was defined as unresolved misalignment or stent
apex protrusion into the aortic wall with clinical effect,
including evidence of endoleak, luminal narrowing of the
endograft, perforation, or type A dissection.
The data collection included the follow-up of the pop-
ulation in the pivotal VALOR trial; direct surveys of centers
within and outside of the United States (OUS), including
participants in sponsor-investigator investigational device
exemption (IDE) studies; a targeted literature search that
included peer-reviewedmedical journals andmajor medicalassociation seminars and conferences; a review of all com-
plaint files to Medtronic related to Talent TSG deployment
in the thoracic aorta; and a reopening of field assurance
research into relevant historical reports.
The survey of OUS centers involved a random sam-
pling of qualifying facilities in Canada and Western Europe
that were the highest volume users, defined as having used
at least one Talent TSG device in the prior year. The survey
plan required an initial sampling based on 3500 ordered
stent grafts, and 96 hospital accounts were surveyed. The
Medtronic OUS sales force and clinical research support
staff were queried with a formal questionnaire regarding
any knowledge of unreported instances of misaligned de-
ployment.
Data updates from the seven US sponsor-investigator
IDE studies of the Talent TSG were reviewed for incidents
of misaligned deployment, aortic perforation, and type A
retrograde aortic dissection, with screening for events that
could be construed as including or related to these phe-
nomena. The data updating included direct surveying of
the principal investigators of the IDE studies.
A review was conducted to identify studies from recog-
nized scientific publications in peer-reviewed journals. Ar-
ticles were limited to those involving the treatment of
human participants, with at least an abstract available in
English. Bibliographies of the retrieved articles were
searched for additional potentially relevant articles. The
retrieved articles included clinical trial reports, review arti-
cles, retrospective analyses, experimental studies, and case
reports.
The incidence was calculated using the total number of
devices deployed because this is a device-specific event and
not a patient-related event; for example, a single patient
might experience this event twice if multiple pieces were
used.
RESULTS
The data collection and review methods described
Fig 1. Left, Drawing depicts a case of misaligned opening of a
Talent Thoracic Stent Graft.Right,Drawing depicts the pull-back
procedure recommended in the Talent device instructions for use
for mitigating a misaligned opening event.identified 24 cases of misaligned deployment of the Talent
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mately 2500 references published through January 2009,
of which 56 articles were determined to be relevant. Five of
the retrieved articles included references to 10 cases of stent
graft maldeployment: 3 with the Talent device (these are
included in Table I) and 7 with other stent graft devi-
ces.10-14
Table II provides a summary of the 24 identified cases
of misaligned deployment, according to the anatomic indi-
cations for stent graft treatment, the stent graft diameter,
the location of the misaligned deployment, clinical se-
quelae, and presumed etiology. In four of these cases, the
device was used to treat a type B aortic dissection (Fig 2). In
one case, the implantation was used to treat a short length
of proximal neck (2 cm) used for the landing zone, and
four other cases involved the use of stent grafts to treat
ascending thoracic aorta or arch pathology. In one other
patient, an abdominal aortic aneurysm was treated with a
thoracic aortic device. The underlying pathology could not
be determined for one event.
Overall, 15 of the 24 events (63%) occurred with use of
large-diameter (40 mm) devices (Fig 3). No misaligned de-
ploymentswereobserved indevices34mm.Nine (38%)of the
misaligned deployments occurred at the overlap of two stent
grafts. Two events were treated intraoperatively with a second
overlapping device in one and a snare repositioning in the other.
Adverse clinical sequelae were documented in relation
to three cases. In one patient with a proximal neck 2 cm
in length, a second stent was deployed to overlap the first
graft, and then a third extension stent graft was incorpo-
rated into the second graft and was brought all the way to
the celiac artery. The entire stent graft was then dilated with
Table I. Adjudicated misaligned deployments of the
Talent Thoracic Stent Graft by study or cohort
Distribution cohort
Implants
No.
Patients
No.
Misalignment
events No.
(% of implanted)
US feasibility studies 102 41 0
US VALOR studies 1056 359 0
US emergency/
compassionate use 1226 316 0
US SI IDE studiesa 1050b 389 3 (0.29)
OUS commercial
sales 15,041c 5571b 6 (0.03)
US commercial sales 1830d 871 15 (0.81)
Total 20,305 7547 24 (0.1%)
OUS, Outside the United States; US SI IDE, United States sponsor-
investigator investigational device exemption studies; VALOR, Evaluation
of the Medtronic Vascular Talent Thoracic Stent Graft System for the
Treatment of Thoracic Aortic Aneurysms.
aAt the time, the Talent Thoracic Stent Graft was the subject of 7 US
sponsor-investigator IDE studies.
bThe number of implants was estimated on the basis of 2.7 devices per
patient (used in the indexed procedure) experienced in the VALOR study.
cApproximated, based on sales from January 2002 to November 8, 2006.
dSales of the TALENT thoracic stent graft since commercial release in the
US.a 46-mm balloon. Despite these corrective measures, aproximal type I endoleak was demonstrated on the postop-
erative computed tomography (CT) scan.
The second case involved treatment for a type B aortic
dissection. The entry tear was inadvertently not covered
during the initial deployment proximal to the left subcla-
vian artery, and angiography revealed that three of the five
proximal bare springs were “bent outward and folded over
the stent graft,” with notation of a type I endoleak in the
false lumen and acute angulation of the graft in the aortic
arch. A CT scan 1 week later revealed continued perfusion
of the false lumen.
In the third patient, successful repositioning of the
misaligned proximal bare spring was achieved through a
transbrachial snare. The proximal bare spring located in the
ascending aorta was used to treat an arch aneurysm after
debranching. A retrograde type A dissection was reported
at the 1-month follow-up CT scan, with no further inter-
vention.
No intraoperative contrast extravasations or CT evi-
dence of perforation was noted in any patients. There were
no perioperative deaths or strokes, with a single report of
paraplegia. The paraplegia was not directly related to the
misaligned deployment because no hypotension or excess
blood loss resulted from this event.
DISCUSSION
Collection of data on device malfunction is critically
important, particularly as new users are exposed to these
devices. These data are often underreported and difficult to
collect, however, because of concerns about potential pa-
tient litigation, regulations protecting patient confidential-
ity, and the inconvenience of assembling and transmitting
complete case data. We used multiple sources of data in an
effort to analyze the true incidence and clinical significance
of this event, including direct requests to physicians at
centers inside and outside the United States who had
experienced misalignment events.
We then reviewed all available clinical data, including
correspondence from implanting physicians and sites, intra-
operative arteriograms, operative dictations, postoperative
CT scans and plain radiographs, and articles or presenta-
tions describing the incidence of these events. We believe
that the thoroughness of this process allowed us to capture
most of themisalignment events that have occurred to date.
Three thoracic stent grafts are currently approved for
use in the United States. Each device is designed to deploy
in a different fashion and has very specific recommenda-
tions for deployment. Additionally, the proximal end of
each of these stent grafts differs, with unique fixation
mechanisms. The TAG (W. L. Gore, Flagstaff, Ariz) was
the only device available in the United States for almost 3
years, during which time most physicians became comfort-
able with its use. This device deploys by the use of a
constraining expanded polytetrafluoroethylene cord that
allows the stent graft to deploy from the middle of the graft
outward. The deployment technique uses constant forward
pressure on the guidewire to align the stent graft against the
outer curvature of the aorta. However, this same technique
left su
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non of misaligned deployment. This is especially true in
large-diameter aortas with short proximal necks. The con-
tinued outward pressure on the wire will force the stent
graft to open in a nonparallel fashion so that the leading end
may fold back on itself (Fig 1).
This deployment outcome may be avoided by allowing
Table II. Summary of cases of misaligned deployment of
Event Treated etiology
1 Indeterminate
2 TAA
3 TAA
4 Penetrating ulcer
5 TAA
6 Existing dissection
7 Existing dissection
8 TAA. Off-label due to coverage of left common carotid
artery
9 TAA. Off-label due to short length of proximal neck
(2 cm)
10 Ascending thoracic placement; total arch repair
11 TAA
12 Dissection of the thoracic aorta
13 Dissection of the thoracic aorta
14 Ulcer at the innominate artery, ascending thoracic aorta
15 TAA
16 TAA
17 TAA
18 TAA
19 TAA
20 TAA
21 AAA
22 TAA
23 TAA
24 TAA
AAA, Abdominal aortic aneurysm; LCC, left common carotid artery; LSA,
Fig 2. Misaligned deployment of the bare spring (arrow) is
shown along the inner curvature of the aorta in a patient with
dissection.the Talent device to maintain the neutral centerline posi-tion during deployment. Almost all proximal type I en-
doleaks are related to failure of the graft to seal to the inner
curvature of the aorta at the distal arch. The proximal bare
springs of the Talent TSG are designed to overcome this
possibility by hugging the inner curve of the distal arch.
However, misaligned deployment can result when the Tal-
ent TSG is held away from the inner curvature of the aorta
and pushed instead against the outer wall during deploy-
ment.
Misaligned deployment is often a predictable phenom-
enon. Two commonly observed causes for misaligned de-
ployment of the Talent device involve (1) an uncorrected
alent Thoracic Stent Graft
Prox TSG
ameter, mm
Location of
misalignment Adverse events
Unknown Unknown None
42 Unknown None
46 Unknown None
36 LSA None
34 LSA None
Unknown LSA Continued false lumen perfusion
34 LSA None
40 LCC None
38 LSA Type I endoleak
46 Unknown New, focal type A dissection
with a tear just proximal to
the sinotubular junction
46 LSA None
44 Unknown None
44 LCC None
46 LCC None
38 Unknown None
42 LCC None
44 LCC None
34 Unknown None
46 Unknown None
46 Unknown None
40 Unknown None
40 Celiac None
40 LSA None
38 Unknown None
bclavian artery; TAA, thoracic aortic aneurysm; TSG, thoracic stent graft.
Fig 3. Stent graft diameters reported in the 24 patients with
misaligned deployment.the T
dimisaligned opening (failure of the stent graft to self-resolve
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misaligned opening by retracting the stent graft distally, or
both) and (2) the pushing proximally of a stent graft that is
only partially opened (forcing the proximal edge of a par-
tially deployed graft forward can force the graft to bend or
buckle within the aorta).
Misaligned deployment is more likely to occur when
the stent graft is used in larger-diameter proximal landing
zones located in the curvature of the distal arch. Such a
scenario can be avoided by selecting relatively healthy aortic
necks with a minimum of 2-cm landing zone. With larger-
diameter devices, a longer landing zone may be preferable,
especially in areas of significant angulation. Table III de-
scribes additional techniques that can be used to prevent
misaligned deployment in challenging proximal necks.
Misaligned deployment is a phenomenon that has been
observed only rarely and infrequently produces adverse
clinical sequelae. The phenomenon does not appear to have
a propensity for a specific underlying thoracic pathology
(degenerative aneurysms vs penetrating ulcers vs type B
dissection; Fig 4). Of note, the Talent TSG is approved for
dissection use OUS but remains an off-label indication in
the United States.
One conclusion that can be drawn from the results of
our extensive literature search is that misaligned deploy-
ment is not unique to the proximal bare spring component,
since 9 of the 24 events (38%) occurred at the overlap zone
between a proximal and distal components, involving the
open-web proximal stent graft configuration that does not
have any bare springs. However, misaligned deployment
has been the focus of very few publications. Our literature
Table III. Techniques for avoiding misaligned
deployment of the Talent Thoracic Stent Graft System
● Allow stent graft to maintain centerline position (neutral)
during deployment
● Keep mean pressure 70 mm Hg
● Anti-impulse therapy for challenging neck anatomy (adenosine
asystole, rapid ventricular pacing, controlled venous inflow
occlusion)
● Avoid constant forward pressure on the guidewire
● Start deployment proximal to intended target and move back
into position
Fig 4. Etiology treated in the 24 patients with misaligned dep-
loyment.search through January 2008 retrieved seven articles relatedto devices other than the Talent and three related to the
Talent.10-14
No instances of misaligned deployment were reported
in the pivotal VALOR trial, which enrolled 195 patients
between December 2003 and June 2005, despite the bare
spring segment of the most proximally implanted Talent
device being located in zone 1 or zone 2 of the aortic arch
in 33.5% of the patients.9
Only three of the misaligned deployments found in this
review had adverse clinical sequelae. One case resulted in a
type I endoleak in a TAA patient, related to the misaligned
deployment. The patient in another case continued to
experience perfusion of the false lumen after implantation
of the endograft for aortic dissection. The last patient
sustained a delayed retrograde type A dissection. Our re-
view determined that the continued perfusion of the false
lumen might have been due to inappropriate landing-zone
selection rather than to the misaligned deployment, but we
had no additional information regarding clinical sequelae in
this patient. In two of these cases with x-ray films available
for review, we believe that the misaligned deployment
might have been prevented by extending the graft more
proximally, covering the left subclavian artery in order to
land the device more proximally in undilated aorta.1
We noted that nine of the events of misaligned deploy-
ment occurred at the overlap of two stent grafts, probably
due to interaction of the overlapping and overlapped grafts
during deployment. No clinical sequelae were reported in
these cases, which involved the open-web proximal stent
graft configuration rather than the bare spring.
In terms of adjudication of causes and potential treat-
ment, we could not determine the exact cause for 3 of the
24 cases of misaligned deployment and therefore could not
determine the appropriate steps necessary to prevent it. Our
review of the remaining 21 events, however, suggested that
the misaligned deployment could have been effectively
prevented by introducing the stent graft proximal to the
appropriate landing zone and then retracting the delivery
system to the target location before complete stent graft
deployment.
Among patients with complete data sets available, five
of the cases were related to improper landing zone selec-
tion: insufficient landing zone in two and a landing zone
proximal to the left carotid artery in three. Two other cases
were related to inappropriate delivery technique: one case
that could have been mitigated by retracting the delivery
system before complete device deployment and one case
that involved advancement of a partially deployed stent
graft.
Once a misaligned deployment is noted, balloon dila-
tation inside the stent graft is not recommended to correct
this phenomenon. On the contrary, balloon repositioning
by means of inflation of an aortic balloon outside the
thoracic device at the level of the everted stent ring may
help reposition the misaligned deployment.
Study limitations. The main drawback is that this
assessment is entirely retrospective on data collections not
intended to investigate misalignment. The data sources
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collected by sales and product persons employed by this
company. There was no doctor or investigator accountabil-
ity for the accuracy of procedure reporting of most of the
cases. Hence, despite an aggressive effort to capture all
misaligned deployment events, this report may represent an
under reporting. Most misalignment events have no imme-
diate adverse clinical sequel, so not all are reported or
recognized. Because imaging studies were not yet available
for most of the events reported in the postapproval phase of
the data collection process, a complete analysis of the causes
of those misalignment events has not yet been possible. In
addition, no data are currently available on the long-term
outcome of patients with these misaligned grafts.
CONCLUSION
Based on a thorough review of all reported cases of
misaligned deployment of the Talent TSG, we believe that
it is an unusual phenomenon that tends to occur in the
context of specific well-defined circumstances and rarely
has immediate clinical implications. It often occurs with the
use of larger-diameter grafts placed in tortuous aortic anat-
omy. Attention to deployment technique along with
proper patient selection, perioperative imaging, and case
planning can help to identify the patients in whom mis-
aligned deployment is more likely to occur and prepare
physicians for using effective measures to prevent these
events. Future device development is underway to prevent
this phenomenon in the form of a “tip capture,” which
involves constriction of the proximal bare stent until the
entire device is deployed.
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The article by Kasirajan et al highlights misalignment of the
Talent Thoracic Stent Graft System (Medtronic Vascular, Santa
Rosa, Calif). As they note in their article, misalignment can and
does occur with all of the currently available thoracic stent graft
systems. It is likely that this evaluation significantly underestimates
the occurrence of this phenomenon, and it is clear that we do not
have a real understanding of why this occurs in each instance.
Misalignment, as defined by a lack of alignment of the stent
graft parallel to the walls of the aorta, occurs muchmore frequently
than noted; however, confining the definition, as the authors have
done, to “retroflexed” proximal stents, which could be considered
severe misalignment, occurs much less frequently. There are sev-
eral intriguing issues regarding the findings and several important
points the authors note as well.
The incidence of this event appears to be much more frequent
in the United States than in Europe, occurring in almost 2% of
patients (1.7% per patient calculation) in the United States com-
mercial sales. Even this incidence is probably under-representing
the true incidence. In addition, although the authors note that this
is more common to occur with larger graft sizes, without knowingsimply increased graft size as the issue. There is no information
regarding the degree of over-sizing and no information regarding
patient features alone, which may be responsible for these issues.
Finally, although limited sequelae have been noted in these cases,
the long-term events for these patients have not been defined, and
it remains to be seen how individuals with these devices will fare,
and in fact, how the devices themselves will fare when deployed in
a manner that is completely outside the anatomic situation for
which they were designed.
Significantly, the authors have pointed out a number of tips
that can be used during deployment that can help to decrease the
occurrence of this problem. Although it is important for any
physician deploying implantable devices to understand how the
device works and how the deployment system works, it is likely
more important to understand how the device and its deployment
mechanism fail and how this can be avoided or managed. The tips
the authors have outlined here should be heeded by those using
these devices, especially in tortuous aortic anatomy. Similar under-
standing of deployment mechanics and the failure modes of the
deployment mechanics would be helpful to understand for all
endovascular grafts, and it is only through publications such as this
